Neuromuscular junction autoantibodies in seronegative myasthenia gravis patients from Sudan

Physiology 2014 (London, UK) (2014) Proc Physiol Soc 31, PCB079

Poster Communications: Neuromuscular junction autoantibodies in seronegative myasthenia gravis patients from Sudan

R. Badi1, A. Musa1, L. Jacobson2, A. Vincent2, A. Ahmed1

1. Physiology, University of Khartoum, Khartoum, Khartoum, Sudan. 2. Nuffield Department of Clinical Neurosciences, Oxford University, Oxford, Oxford, United Kingdom.

View other abstracts by:


Background: In Myasthenia gravis (MG), autoantibodies target neuromuscular junctions (NMJ) proteins leading to a decreased sensitivity to ACh with muscle weakness. 80- 88% of MG patients have AChR antibodies (AChR-Ab+ve). It was suggested that AChR-Ab-ve patients may have autoantibodies against other NMJ proteins or a more sensitive assay is required to detect AChR-Abs. Hoech, etal (2001) detected Muscle specific kinase antibodies (MuSK-Abs) in 70% of AChR-Ab-ve generalized MG patients (GMG). Leite, etal (2008) detected clustered AChR-Abs by the cell based assay (CBA) in 66% of AChR-Ab-ve patients. A considerable proportion of MG patients remain seronegative for NMJ autoantibodies (SN-MG). Objectives:To identify the nature of NMJ autoantibodies in AChR-Ab-ve MG patients from Sudan and to relate it to their clinical presentationPatients and Methods: 96 MG patients (77 GMG and 19 OMG) were randomly recruited from two national MG referral centers in Khartoum during the period 2010- 2012. All patients were screened for AChR-Abs and MuSK-Abs by radioimmunoprecipitation assay (RIPA). Negative sera were screened for clustered AChR-Abs by the CBA.Results: 62.5% (60/96) of patients were AChR-Ab+ve by RIPA. Of the 36 AChR-Ab-ve patients, 19.4% (7/36) were MuSK-Ab+ve, and 22.2% (8/36) were Clustered AChR-Ab+ve. 21.9% (21/96) of patients remained SN-MG. MuSK-Ab+ve patients (MuSK-MG) represented 25.9% (7/27) of AChR-Ab-ve GMG with a female: male ratio of 1.3:1 and dominant bulbar symptoms (85.7%, 6/7). Clustered AChR-Ab+ve patients were all females (n=8). SN-GMG were predominantly females (92.9%, 13/14) (P=0.02). The incidence of an associated autoimmune thyroid gland disease (AUID) in SN-GMG females was 53.8% (7/13) compared to 17.6% (6/34) in AChR-Ab+ve GMG females (P<.013), RR (95% CI)=3.05 (1.3-7.38).Conclusion: In MG patients with ACHR-Ab -ve by the RIPA, only 58.3% were found to be truly seronegative to known MG antibodies, 19.4% were MuSK MG and 22% were positive to clustered AChR-Ab. The association between AUID and SN-GMG females suggests the involvement of sex and predisposition to autoimmune thyroid gland diseases in the pathogenesis of SN-MG



Where applicable, experiments conform with Society ethical requirements.

Site search

Filter

Content Type